key: cord-0983049-b3u8n0y3
authors: Ilonzo, Nicole; Kumar, Shivani; Borazan, Nabeel; Hansen, Thomas; Rao, Ajit; Lantis, John; Faries, Peter; Ting, Windsor
title: Endotheliitis in COVID-19-positive patients after extremity amputation for acute thrombotic events
date: 2020-12-30
journal: Ann Vasc Surg
DOI: 10.1016/j.avsg.2020.12.004
sha: 449961d1a0e962e7c3932faf0d87b614fa9230c6
doc_id: 983049
cord_uid: b3u8n0y3

INTRODUCTION: Both arterial and venous thrombotic events of the extremities occur in COVID-19 infection, but the etiology of these events remains unclear. This study sought to evaluate pathology specimens of COVID-19 positive patients post-amputation, who were found to have Rutherford 3 acute limb ischemia requiring amputation. METHODS: A retrospective review was performed of all vascular surgery emergency room and inpatient consultations in patients who presented to the Mount Sinai Health System from March 26, 2020 to May 10, 2020. Pathology specimens were examined using hematoxylin and eosin (H&E) stain. The specimens were assessed for the following: inflammatory cells associated with endothelium/apoptotic bodies, mononuclear cells, small vessel congestion, and lymphocytic endotheliitis. Of the specimens evaluated, two patients with a known history of peripheral vascular disease were excluded. RESULTS: Inflammatory cells associated with endothelium/apoptotic bodies were seen in all four patients and in four out of five specimens. Mononuclear cells were found in two out of four patients. Small vessel congestion was seen in all patients. Lymphocytic endotheliitis was seen in one out of four patients. CONCLUSION: This study shows endotheliitis in amputation specimens of four patients with COVID-19 disease and Rutherford Class 3 acute limb ischemia. The findings in these patients is more likely an infectious angiitis due to COVID-19.

Inflammatory cells associated with endothelium/apoptotic bodies were seen in all four patients 34 and in four out of five specimens. Mononuclear cells were found in two out of four patients.

Small vessel congestion was seen in all patients. Lymphocytic endotheliitis was seen in one out

Patients with COVID-19 disease are hypercoagulable. 1, 2 The etiology of hypercoagulability is 45 not completely understood but may be due to underlying endotheliitis. 3, 4 Previous studies have 46 shown evidence of endotheliitis in postmortem examination of COVID-19 patients 5 . These studies have shown diffuse alveolar damage in the respiratory tract, lymphocyte infiltration in the 48 alveolar space 5 with evidence of pulmonary embolism in some studies. 6 There is evidence of (Table 1) . 

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Endothelial cell infection and endotheliitis in COVID-19

Postmortem Examination of Patients With COVID-19

Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive

Acute limb ischemia in patients with COVID-19 pneumonia

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Risk of peripheral arterial thrombosis in COVID-19

Upsurge of deep venous thrombosis in patients affected by COVID-19: Preliminary data and possible explanations

Extrapulmonary manifestations of COVID-19

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

COVID-19-associated vasculitis and vasculopathy

Acute thrombotic events as initial presentation of patients with COVID-19 infection

Pathology of Peripheral Artery Disease in Patients With Critical Limb Ischemia

Detection of Rickettsia Endosymbiont Bemisia Tabaci in the Amputated Limbs of Three Buerger's Disease Patients

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Collapsing glomerulopathy in a COVID-19 patient

Electron microscopy of SARS-CoV-2: a challenging task